Author:
Moraes Adriel S.,Boldrini Vinicius O.,Dionete Alliny C.,Andrade Marilia D.,Longhini Ana Leda F.,Santos Irene,Lima Amanda D. R.,Silva Veronica A. P. G.,Dias Carneiro Rafael P. C.,Quintiliano Raphael P. S.,Ferrari Breno B.,Damasceno Alfredo,Pradella Fernando,Farias Alessandro S.,Tilbery Charles P.,Domingues Renan B.,Senne Carlos,Fernandes Gustavo B. P.,von Glehn Felipe,Brandão Carlos Otavio,Stella Carla R. A. V.,Santos Leonilda M. B.
Abstract
BackgroundNeurofilament Light (NfL) chain levels in both cerebrospinal fluid (CSF) and serum have been correlated with the reduction of axonal damage in multiple sclerosis (MS) patients treated with Natalizumab (NTZ). However, little is known about the function of plasmacytoid cells in NTZ-treated MS patients.ObjectiveTo evaluate CSF NfL, serum levels of soluble-HLA-G (sHLA-G), and eventual tolerogenic behavior of plasmacytoid dendritic cells (pDCs) in MS patients during NTZ treatment.MethodsCSF NfL and serum sHLA-G levels were measured using an ELISA assay, while pDCs (BDCA-2+) were accessed through flow cytometry analyses.ResultsCSF levels of NfL were significantly reduced during NTZ treatment, while the serum levels of sHLA-G were increased. Moreover, NTZ treatment enhanced tolerogenic (HLA-G+, CD274+, and HLA-DR+) molecules and migratory (CCR7+) functions of pDCs in the peripheral blood.ConclusionThese findings suggest that NTZ stimulates the production of molecules with immunoregulatory function such as HLA-G and CD274 programmed death-ligand 1 (PD-L1) which may contribute to the reduction of axonal damage represented by the decrease of NfL levels in patients with MS.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Subject
Cellular and Molecular Neuroscience
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献